Neuraxis Inc (NRXS)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Neuraxis Inc Stock (NRXS) Company Profile

Neuraxis Inc

Healthcare (1117)

Biotechnology (624)

(812) 689-0791

11550 North Meridian Street, Suite 325, Carmel

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NRXS's Discussions on Twitter

Compare NRXS vs VRTX, REGN, ARGX, ALNY, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NRXS Neuraxis Inc	7.23	81.11M	3.57M	-7.80M	-6.56M	-0.9703
VRTX Vertex Pharmaceuticals Inc	433.56	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	762.84	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	748.14	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	330.59	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	163.86	35.01B	606.42M	-1.28B	-997.58M	-6.403

Neuraxis Inc Aktie (NRXS) Neueste Nachrichten

Finanzdaten der Neuraxis Inc-Aktie (NRXS)

Neuraxis Inc-Aktie (NRXS) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Carrico Thomas Joeseph	CRO, CCO, CPO	Apr 01 '26	Buy	1.96	667	1,307	331,903
Carrico Brian Allen	Chief Executive Officer	Apr 01 '26	Buy	1.96	8,060	15,798	348,178
Hannasch Brian	10% Owner	Feb 12 '26	Buy	4.92	40,000	196,800	1,211,522
Hannasch Brian	10% Owner	Feb 11 '26	Buy	4.65	40,000	186,000	1,171,522
Aharon Gil	Director	Dec 23 '25	Buy	3.52	286,138	1,007,206	286,138
MASIMO CORP	10% Owner	Jul 01 '25	Sale	2.25	821,327	1,847,986	0
Hannasch Brian	10% Owner	Jul 01 '25	Buy	2.25	355,556	800,001	1,131,522
Hannasch Brian	10% Owner	Apr 21 '25	Buy	1.73	18,065	31,251	775,966

Neuraxis Inc (NRXS)

Neuraxis Inc Stock (NRXS) Company Profile

Compare NRXS vs VRTX, REGN, ARGX, ALNY, INSM

Neuraxis Inc Aktie (NRXS) Neueste Nachrichten

Winners Losers: Does NeurAxis Inc have pricing powerQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

NeurAxis (NASDAQ:NRXS) CFO Buys $14,882.28 in Stock - Defense World

NRXS PE Ratio & Valuation, Is NRXS Overvalued - Intellectia AI

Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys - TipRanks

Neuraxis CEO Carrico buys $15,797 in company stock By Investing.com - Investing.com Australia

Neuraxis CFO Henrichs buys $14,882 in company stock - Investing.com

Neuraxis Inc: CRO Carrico buys $1307 in shares By Investing.com - Investing.com India

Neuraxis CFO Henrichs buys $14,882 in company stock By Investing.com - Investing.com South Africa

Insider Buying: NeurAxis (NASDAQ:NRXS) CFO Buys 7,593 Shares of Stock - MarketBeat

Insider Buying: NeurAxis (NASDAQ:NRXS) CEO Buys 8,060 Shares of Stock - MarketBeat

Neuraxis Inc: CRO Carrico buys $1307 in shares - Investing.com

Neuraxis (NRXS) CFO acquires 7,593 shares at $1.96 in open trade - Stock Titan

Neuraxis (NRXS) executive makes small open-market share purchase - Stock Titan

Neuraxis (NRXS) CEO boosts stake with open-market buy of 8,060 shares - Stock Titan

Aug Final Week: Is NeurAxis Inc a speculative investmentVolume Spike & Real-Time Stock Movement Alerts - baoquankhu1.vn

New Highs: Can NeurAxis Inc expand its profit marginsQuarterly Investment Review & Real-Time Stock Entry Alerts - baoquankhu1.vn

Insider Trends: Does NeurAxis Inc have pricing power2026 Levels & Technical Confirmation Alerts - baoquankhu1.vn

Treasury Yields: Should I trade or invest in NeurAxis Inc2026 Pullbacks & Capital Efficiency Focused Ideas - baoquankhu1.vn

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - TradingView

NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion - Bitget

If You Invested $1,000 in Neuraxis Inc (NRXS) - Stock Titan

Craig Hallum Increases NeurAxis (NASDAQ:NRXS) Price Target to $13.00 - Defense World

Dip Buying: Can NeurAxis Inc outperform under higher oil prices2026 Trading Recap & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Gainers Report: Can NeurAxis Inc expand its profit marginsEarnings Beat & AI Powered Market Entry Ideas - baoquankhu1.vn

Neuraxis, Inc.: Fundamental Analysis and Financial Ratings | NRXS | US64134X2018 - marketscreener.com

NeurAxis (NASDAQ:NRXS) Given New $13.00 Price Target at Craig Hallum - MarketBeat

NeurAxis revenue up 27% year to USD 968000 in Q4FY25 - Medical Buyer

NeurAxis Earnings Call: Reimbursement Wins Drive Next Phase - TipRanks

Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com Australia

NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

NeurAxis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

NRXS: FY2025 revenue rose 33% to $3.6M, with improved net loss and expanded market access - tradingview.com

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph

Neuraxis 10-K: $3.57M Revenue, $(7.80)M Net Loss - TradingView

Neuraxis (NRXS) expands IB-Stim GI neuromodulation, RED constipation device and IP moat - Stock Titan

Neuraxis reports strong fourth quarter and full year 2025 financial results - marketscreener.com

Levels Update: Should I trade or invest in NeurAxis Inc2026 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn

Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail

Aug Ideas: What is the implied volatility of NeurAxis Inc2026 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

NeurAxis, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

NeurAxis, Inc. Hits New 52-Week High of $7.46, Up 141.44% - Markets Mojo

Breakout Zone: Is NeurAxis Inc impacted by rising ratesTrade Exit Report & Stock Portfolio Risk Control - baoquankhu1.vn

NeurAxis, Inc. Hits New 52-Week High at USD 7.34 - Markets Mojo

Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Sahm

Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan

Stock List: Research Stocks from Around the World - GuruFocus

NeurAxis (NASDAQ:NRXS) Shares Up 0.7%Still a Buy? - MarketBeat

Finanzdaten der Neuraxis Inc-Aktie (NRXS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Neuraxis Inc-Aktie (NRXS) Insiderhandel

Ähnlich wie NRXS